Palisade Bio (PALI) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.03% |
| Dec 31, 2025 | 118.05% |
| Sep 30, 2025 | -36.31% |
| Jun 30, 2025 | -14.63% |
| Mar 31, 2025 | 3.62% |
| Dec 31, 2024 | 0.57% |
| Sep 30, 2024 | 19.01% |
| Jun 30, 2024 | 45.08% |
| Mar 31, 2024 | 35.75% |
| Dec 31, 2023 | 38.93% |
| Sep 30, 2023 | 45.75% |
| Jun 30, 2023 | 49.67% |
| Mar 31, 2023 | 49.54% |
| Dec 31, 2022 | 51.80% |
| Sep 30, 2022 | 20.85% |
| Jun 30, 2022 | 28.98% |
| Mar 31, 2022 | 13.56% |
| Dec 31, 2021 | 6.78% |
| Sep 30, 2021 | -4.35% |
| Jun 30, 2021 | -52.25% |
| Mar 31, 2021 | -71.41% |
| Dec 31, 2020 | -58.07% |
| Sep 30, 2020 | -45.98% |
| Jun 30, 2020 | -52.09% |
| Mar 31, 2020 | -44.96% |
| Dec 31, 2019 | -39.85% |
| Sep 30, 2019 | 56.88% |
| Jun 30, 2019 | 32.88% |
| Mar 31, 2019 | 177.27% |
| Dec 31, 2018 | 6.79% |
| Sep 30, 2018 | -20.47% |
| Jun 30, 2018 | -24.83% |
| Mar 31, 2018 | -30.12% |
| Dec 31, 2017 | -21.67% |
| Sep 30, 2017 | -17.91% |
| Jun 30, 2017 | -31.59% |
| Mar 31, 2017 | -28.63% |
| Dec 31, 2016 | 10.41% |
| Sep 30, 2016 | -34.95% |
| Jun 30, 2016 | -42.55% |
| Mar 31, 2016 | -26.61% |
| Dec 31, 2015 | -10.69% |
| Sep 30, 2015 | -0.72% |
| Jun 30, 2015 | 80.11% |
| Mar 31, 2015 | 62.23% |
| Dec 31, 2014 | 120.19% |
| Sep 30, 2014 | 74.97% |
| Jun 30, 2014 | 56.53% |
| Dec 31, 2013 | 2.34% |